[go: up one dir, main page]

Latest News for: molecular

Edit

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712 (Form 6-K) (Molecular Partners AG)

Public Technologies 02 Jul 2026
Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712 Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712 ... 53 LR - Molecular Partners AG (SIX.
Edit

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712 (Molecular Partners AG)

Public Technologies 02 Jul 2026
53 LR - Molecular Partners AG (SIX ... Molecular Partners develops targeted alpha therapeutics leveraging its Radio-DARPins as isotope-agnostic vectors with the potential to unlock a broad range of cancer targets and indications ... Molecular Partners..
Edit

German Research Foundation to Fund New Research Unit: Investigating the Molecular Machines at the Heart of Gene Expression (Freie Universität Berlin)

Public Technologies 02 Jul 2026
Investigating the Molecular Machines at the Heart of Gene Expression ... These molecular machines transcribe DNA into RNA and drive the transcription cycle through the phases of initiation, elongation, and termination.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (4D Molecular Therapeutics Inc)

Public Technologies 02 Jul 2026
) FORM 4. Check this box if no longer subject to Section 16 ... See Instruction 1(b) ... OMB Number ... 4D Molecular Therapeutics, Inc ... C/O 4D MOLECULAR THERAPEUTICS, INC., 5858 HORTON STREET #455 3 ... C/O 4D MOLECULAR THERAPEUTICS, INC ... 4D Molecular Therapeutics Inc.
Edit

Nuclear Medicine Market to Reach $21.01 Billion by 2030, Driven by Growth in Molecular Imaging ...

GetNews 01 Jul 2026
This robust growth is driven by the increasing adoption of molecular imaging, rising demand for theranostics, and continuous advancements in radiopharmaceutical development ... Download PDF Brochure. ... Diagnostic Segment Leads the Market ... Related Reports..
Edit

Inside the Lab: Spotlight on Molecular Innovation – Q&A with El Mustapha Bahassi, PhD (Medpace Holdings Inc)

Public Technologies 30 Jun 2026
) As precision medicine continues to reshape drug development, molecular and genomic testing have become essential for understanding disease biology, identifying biomarkers, and evaluating therapeutic response.
Edit

In 2025, astronomers discovered Eos, the closest dark molecular cloud ever found — a vast ...

SpaceDaily 30 Jun 2026
In 2025, astronomers found one of the closest molecular clouds to the Sun, and it had been sitting almost on our doorstep the whole time, unseen. Named Eos, it is a vast crescent of molecular hydrogen about 300 light-years away.
×